We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
20 hedge funds and large institutions have $910K invested in CASI Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
11% more funds holding
Funds holding: 18 → 20 (+2)
0.19% less ownership
Funds ownership: 2.08% → 1.89% (-0.19%)
54% less capital invested
Capital invested by funds: $1.99M → $910K (-$1.08M)
Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HCM
Howland Capital Management
Boston,
Massachusetts
|
+$218K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$64.6K |
| 3 |
Renaissance Technologies
New York
|
+$41.5K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$3.07K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.69K |
Top Sellers
| 1 |
WSCM
Wellington Shields Capital Management
New York
|
-$220K |
| 2 |
Franklin Resources
San Mateo,
California
|
-$144K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$93.9K |
| 4 |
Jane Street
New York
|
-$89.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8.75K |
